The following review discusses the successful application of X-ray, NMR, and molecular modeling in the design of potent and selective inhibitors of matrix metalloproteinases (MMPs) and TNFα-converting enzyme (TACE) from Wyeth. The importance of protein and ligand mobility as it impacts structure-based design is also discussed. The MMPs are an active target for a variety of diseases, including cancer and arthritis.
No takes yet. Share an insight, caveat, or question.
Rush et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: